Claudio Belluco
Overview
Explore the profile of Claudio Belluco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spolverato G, Bao Q, Delrio P, Guerrieri M, Ortenzi M, Cillara N, et al.
Int J Surg
. 2024 Mar;
110(8):4736-4745.
PMID: 38518084
Background: Rectal-sparing approaches for patients with rectal cancer who achieved a complete or major response following neoadjuvant therapy constitute a paradigm of a potential shift in the management of patients...
2.
Coco C, Delrio P, Rega D, Amodio L, Pucciarelli S, Spolverato G, et al.
Colorectal Dis
. 2023 Dec;
26(2):281-289.
PMID: 38131642
Aim: Local excision (LE) in selected cases after neoadjuvant radiochemotherapy (RCT) for locally advanced rectal cancer in clinically complete or major responders has been recently reported as an alternative to...
3.
Ministrini S, Bencivenga M, Filippini F, Mura G, Milandri C, Mazzei M, et al.
Eur J Surg Oncol
. 2023 Nov;
50(1):107275.
PMID: 37995604
Introduction: The Italian Research Group for Gastric Cancer developed a prospective database about stage IV gastric cancer, to evaluate how a pragmatic attitude impacts the management of these patients. Materials...
4.
Buonadonna A, Scalone S, Lombardi D, Fumagalli A, Guglielmi A, Lestuzzi C, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894403
Doxorubicin is a widely used anticancer agent as a first-line treatment for various tumor types, including sarcomas. Its use is hampered by adverse events, among which is the risk of...
5.
Degiuli M, Ortenzi M, Tomatis M, Puca L, Cianflocca D, Rega D, et al.
Surg Endosc
. 2023 May;
37(6):5008-5009.
PMID: 37160809
No abstract available.
6.
Degiuli M, Ortenzi M, Tomatis M, Puca L, Cianflocca D, Rega D, et al.
Surg Endosc
. 2022 Sep;
37(2):977-988.
PMID: 36085382
Background: Evidence on the efficacy of minimally invasive (MI) segmental resection of splenic flexure cancer (SFC) is not available, mostly due to the rarity of this tumor. This study aimed...
7.
Bao Q, Pellino G, Spolverato G, Restivo A, Deidda S, Capelli G, et al.
Int J Colorectal Dis
. 2022 Jun;
37(7):1689-1698.
PMID: 35773492
Purpose: The impact of anastomotic leaks (AL) on oncological outcomes after low anterior resection for mid-low rectal cancer is still debated. The aim of this study was to evaluate overall...
8.
Fornasarig M, Capuano A, Maiero S, Pivetta E, Canzonieri V, Belluco C, et al.
Clin Exp Med
. 2022 Jun;
23(2):547-551.
PMID: 35650372
Linitis plastica (LP) is a very aggressive and rare carcinoma with a scirrhous stroma that affects the submucosal and muscular layers of the stomach even without mucosal alterations. Lack of...
9.
De Mattia E, Canzonieri V, Polesel J, Mezzalira S, Dalle Fratte C, Dreussi E, et al.
Front Pharmacol
. 2022 Jan;
12:778781.
PMID: 35002714
Identifying patients at risk of poor response to neoadjuvant chemoradiotherapy (nCRT) is an emerging clinical need in locally advanced rectal cancer (LARC). SMAD3 is a key player in the chemoradio-resistance...
10.
Marchegiani F, Palatucci V, Capelli G, Guerrieri M, Belluco C, Rega D, et al.
Ann Surg Oncol
. 2021 Dec;
29(3):1880-1889.
PMID: 34855063
Background: Rectum-preservation for locally advanced rectal cancer has been proposed as an alternative to total mesorectal excision (TME) in patients with major (mCR) or complete clinical response (cCR) after neoadjuvant...